Clinical Trial: A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)

Brief Summary: The purpose of this study is to confirm the efficacy of Aricept in patients with dementia with Lewy bodies (DLB).

Detailed Summary:
Sponsor: Eisai Co., Ltd.

Current Primary Outcome: Clinician's Interview-Based Impression of Change, Plus Caregiver Input Version (CIBIC-plus) [ Time Frame: Up to 12 weeks ]

CIBIC plus is a clinician's interview-based impression of change plus the caregiver's input. It is a seven-point categorical assessment scale for evaluating global clinical function, ranging from "markedly improved" to "markedly worse".


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Eisai Inc.

Dates:
Date Received: January 19, 2015
Date Started: March 2015
Date Completion: May 2018
Last Updated: December 1, 2016
Last Verified: November 2016